InvestorsHub Logo
Followers 29
Posts 4103
Boards Moderated 0
Alias Born 12/01/2009

Re: nealg post# 32969

Tuesday, 06/14/2016 9:45:19 AM

Tuesday, June 14, 2016 9:45:19 AM

Post# of 97081
Well said.

I agree with the $0.05 - $0.10/share. It would be hard to place a PE multiple in that for me. If you look at other growth biotech companies that have gone from negative eps to positive the PE multiple typically shows more in the range of 50+. We need to see how the market accepts GenUltimate and the other new products that will be introduced.